Multiple Myeloma: From MGUS to Active Disease
Understand the progression of multiple myeloma, key risk factors, and the clinical milestones used to diagnose and monitor patients.
Join Sebia Experts as they explore the medical solutions and impacts of various diseases, including Diabetes, Hemoglobinopathies, Multiple Myeloma, among others. Watch the on-demand series featuring Dr. Matt Wagner, Mimi Ulloa, and other experts as they explain the available diagnostic solutions for patient diagnosis and monitoring.
Learn about Free Light Chain testing in the US population and hear from Mimi ULLOA about solutions offered by Sebia
Understand the progression of multiple myeloma, key risk factors, and the clinical milestones used to diagnose and monitor patients.
Learn how serum free light chain ratios support diagnosis, risk stratification, treatment monitoring, and relapse detection throughout the patient journey.
Discover how Sebia's automated serum free light chain solution helps overcome common testing limitations while improving efficiency, reproducibility, and laboratory performance.
Serum free light chain ratios are crucial to diagnosing multiple myeloma and monitoring the disease throughout its progression
No content available.
This section contains information intended for wide distribution and may therefore contain product details or information that is not available or valid in your country. Please contact your local Sebia representative. Information intended for healthcare professionals. Carefully read the instructions in the reagent package inserts and instrument manuals.